The History of Racism and Cannabis:
- megan boynton
- Aug 23, 2024
- 3 min read
The Path to Schedule I
The classification of cannabis as a Schedule I narcotic under U.S. federal law is a deeply controversial decision, rooted in a complex history of racism, social control, and political maneuvering. This classification, which deems cannabis to have "no accepted medical use and a high potential for abuse," has profound implications for criminal justice, public health, and racial inequality. To understand how cannabis arrived at this status, one must delve into the early 20th century, where racial prejudices and political agendas intertwined to shape drug policy.
The Early 20th Century: Seeds of Stigmatization
The stigmatization of cannabis in the United States began in the early 1900s, coinciding with a period of intense social change and migration. Cannabis, widely used in medicinal products during the 19th century, came under scrutiny as Mexican immigrants introduced recreational smoking of the plant, which they called "marihuana." This new form of use was associated with immigrant communities, leading to a racialized perception of the drug.
Media sensationalism played a crucial role in this stigmatization. Newspapers, led by figures like William Randolph Hearst, published exaggerated and often false stories linking cannabis use to violent crime, insanity, and deviant behavior. These stories frequently portrayed Mexican and African American users as dangerous and morally corrupt, fueling public fear and prejudice.
The Marijuana Tax Act of 1937
In 1930, Harry Anslinger was appointed the first commissioner of the Federal Bureau of Narcotics (FBN). Anslinger was a staunch prohibitionist who capitalized on the racial prejudices of the time to advance his anti-cannabis agenda. He famously declared that "reefer makes darkies think they’re as good as white men" and used similar rhetoric to garner support for strict cannabis regulation.
Anslinger's efforts culminated in the Marijuana Tax Act of 1937, which effectively criminalized cannabis by imposing heavy taxes and strict regulations on its production and distribution. The Act was passed with little scientific basis, driven instead by racial and xenophobic fears. This legislation laid the groundwork for the future criminalization and stigmatization of cannabis users, disproportionately affecting communities of color.
The Controlled Substances Act of 1970
The next significant milestone in the history of cannabis regulation was the Controlled Substances Act (CSA) of 1970. By this time, the cultural landscape had shifted, with the counterculture movement of the 1960s embracing cannabis as a symbol of rebellion against mainstream societal norms. This association with the counterculture, alongside ongoing racial prejudices, influenced the federal government's approach to drug policy.
President Richard Nixon, a fierce opponent of the counterculture, launched the "War on Drugs," framing drug abuse as a national security threat. In 1971, Nixon's own National Commission on Marihuana and Drug Abuse (commonly known as the Shafer Commission) recommended decriminalizing cannabis possession, citing minimal harm and no significant link to violent crime. However, Nixon dismissed these findings, driven by political motives.
John Ehrlichman, Nixon’s domestic policy chief, later revealed the administration’s true intent: “We knew we couldn’t make it illegal to be either against the war or black, but by getting the public to associate the hippies with marijuana and blacks with heroin, and then criminalizing both heavily, we could disrupt those communities.” This candid admission highlights the deliberate use of drug policy as a tool for social control, particularly targeting African Americans and anti-war activists.
The Legacy of Schedule I Classification
The CSA classified cannabis as a Schedule I drug, alongside heroin and LSD. This classification has had lasting and devastating impacts on minority communities. African Americans and Latinos have been disproportionately arrested and incarcerated for cannabis-related offenses, despite similar usage rates among white individuals. These disparities have contributed to systemic racial inequalities in the criminal justice system, with long-term social and economic consequences for affected communities.
Additionally, the Schedule I classification has hindered scientific research into the potential medical benefits of cannabis. Despite growing evidence supporting its therapeutic use for conditions such as chronic pain, epilepsy, and PTSD, federal restrictions have limited researchers' ability to conduct comprehensive studies.
Conclusion
The history of cannabis regulation in the United States is inextricably linked to racial prejudice and political manipulation. From the racially charged rhetoric of the early 20th century to the strategic criminalization efforts of the Nixon administration, cannabis has been used as a tool to marginalize and control minority communities. Understanding this history is crucial for addressing the ongoing impacts of these policies and moving towards a more equitable and evidence-based approach to cannabis regulation. As the nation continues to grapple with the legacy of these decisions, the call for reform and justice grows louder, demanding a reevaluation of cannabis's place in American society and law.
Comments